Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

1.

Stromal micropapillary component as a novel unfavorable prognostic factor of lung adenocarcinoma.

Ohe M, Yokose T, Sakuma Y, Miyagi Y, Okamoto N, Osanai S, Hasegawa C, Nakayama H, Kameda Y, Yamada K, Isobe T.

Diagn Pathol. 2012 Jan 6;7:3. doi: 10.1186/1746-1596-7-3.

PMID:
22225786
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Pulmonary adenocarcinoma with a micropapillary pattern: a clinicopathological, immunophenotypic and molecular analysis.

Zhang J, Liang Z, Gao J, Luo Y, Liu T.

Histopathology. 2011 Dec;59(6):1204-14. doi: 10.1111/j.1365-2559.2011.04050.x.

PMID:
22175900
[PubMed - indexed for MEDLINE]
3.

Stromal micropapillary pattern predominant lung adenocarcinoma--a report of two cases.

Ohe M, Yokose T, Sakuma Y, Osanai S, Hasegawa C, Washimi K, Nawa K, Woo T, Hamanaka R, Nakayama H, Kameda Y, Yamada K, Isobe T.

Diagn Pathol. 2011 Sep 29;6:92. doi: 10.1186/1746-1596-6-92.

PMID:
21955603
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma.

Kamiya K, Hayashi Y, Douguchi J, Hashiguchi A, Yamada T, Izumi Y, Watanabe M, Kawamura M, Horinouchi H, Shimada N, Kobayashi K, Sakamoto M.

Mod Pathol. 2008 Aug;21(8):992-1001. doi: 10.1038/modpathol.2008.79. Epub 2008 May 30.

PMID:
18516041
[PubMed - indexed for MEDLINE]
Free Article
5.

A micropapillary pattern is predictive of a poor prognosis in lung adenocarcinoma, and reduced surfactant apoprotein A expression in the micropapillary pattern is an excellent indicator of a poor prognosis.

Tsutsumida H, Nomoto M, Goto M, Kitajima S, Kubota I, Hirotsu Y, Wakimoto J, Hollingsworth MA, Yonezawa S.

Mod Pathol. 2007 Jun;20(6):638-47. Epub 2007 Apr 13.

PMID:
17431413
[PubMed - indexed for MEDLINE]
Free Article
6.

Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients.

Russell PA, Barnett SA, Walkiewicz M, Wainer Z, Conron M, Wright GM, Gooi J, Knight S, Wynne R, Liew D, John T.

J Thorac Oncol. 2013 Apr;8(4):461-8. doi: 10.1097/JTO.0b013e3182828fb8.

PMID:
23486266
[PubMed - indexed for MEDLINE]
7.

Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis.

Motoi N, Szoke J, Riely GJ, Seshan VE, Kris MG, Rusch VW, Gerald WL, Travis WD.

Am J Surg Pathol. 2008 Jun;32(6):810-27. doi: 10.1097/PAS.0b013e31815cb162.

PMID:
18391747
[PubMed - indexed for MEDLINE]
8.

Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.

Yoshizawa A, Sumiyoshi S, Sonobe M, Kobayashi M, Fujimoto M, Kawakami F, Tsuruyama T, Travis WD, Date H, Haga H.

J Thorac Oncol. 2013 Jan;8(1):52-61. doi: 10.1097/JTO.0b013e3182769aa8.

PMID:
23242438
[PubMed - indexed for MEDLINE]
9.

Pulmonary adenocarcinomas with micropapillary component significantly correlate with recurrence, but can be well controlled with EGFR tyrosine kinase inhibitors in the early stages.

Sumiyoshi S, Yoshizawa A, Sonobe M, Kobayashi M, Fujimoto M, Tsuruyama T, Date H, Haga H.

Lung Cancer. 2013 Jul;81(1):53-9. doi: 10.1016/j.lungcan.2013.04.003. Epub 2013 Apr 28.

PMID:
23632273
[PubMed - indexed for MEDLINE]
10.

Micropapillary lung adenocarcinoma: a distinctive histologic subtype with prognostic significance. Case series.

Sánchez-Mora N, Presmanes MC, Monroy V, Moreno N, Lara-Martínez JM, Aladro MH, Alvarez-Fernández E.

Hum Pathol. 2008 Mar;39(3):324-30. doi: 10.1016/j.humpath.2007.05.029.

PMID:
18261622
[PubMed - indexed for MEDLINE]
11.

[Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].

Liu B, Shi SS, Wang X, Xu Y, Zhang XH, Yu B, Lu ZF, Wang JD, Zhou XJ.

Zhonghua Bing Li Xue Za Zhi. 2012 Aug;41(8):505-10. doi: 10.3760/cma.j.issn.0529-5807.2012.08.001. Chinese.

PMID:
23157740
[PubMed - indexed for MEDLINE]
12.

Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (</=20 mm) with mixed bronchioloalveolar and invasive subtypes (Noguchi's type C tumours).

Makimoto Y, Nabeshima K, Iwasaki H, Miyoshi T, Enatsu S, Shiraishi T, Iwasaki A, Shirakusa T, Kikuchi M.

Histopathology. 2005 Jun;46(6):677-84.

PMID:
15910599
[PubMed - indexed for MEDLINE]
13.

Colorectal micropapillary carcinomas are associated with poor prognosis and enriched in markers of stem cells.

Lee HJ, Eom DW, Kang GH, Han SH, Cheon GJ, Oh HS, Han KH, Ahn HJ, Jang HJ, Han MS.

Mod Pathol. 2013 Aug;26(8):1123-31. doi: 10.1038/modpathol.2012.163. Epub 2012 Oct 12.

PMID:
23060121
[PubMed - indexed for MEDLINE]
14.

EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases.

Han HS, Eom DW, Kim JH, Kim KH, Shin HM, An JY, Lee KM, Choe KH, Lee KH, Kim ST, Koo JH, Lee HC, Lee OJ.

Clin Lung Cancer. 2011 Nov;12(6):380-6. doi: 10.1016/j.cllc.2011.02.006. Epub 2011 May 20.

PMID:
21729655
[PubMed - indexed for MEDLINE]
15.

Tumor islands in resected early-stage lung adenocarcinomas are associated with unique clinicopathologic and molecular characteristics and worse prognosis.

Onozato ML, Kovach AE, Yeap BY, Morales-Oyarvide V, Klepeis VE, Tammireddy S, Heist RS, Mark EJ, Dias-Santagata D, Iafrate AJ, Yagi Y, Mino-Kenudson M.

Am J Surg Pathol. 2013 Feb;37(2):287-94. doi: 10.1097/PAS.0b013e31826885fb.

PMID:
23095504
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Pulmonary adenocarcinoma with micropapillary component: an immunohistochemical study. Case report.

Kuroda N, Hamauzu T, Toi M, Yamaoka K, Miyazaki E, Hiroi M, Nakata H, Taguchi H, Enzan H.

APMIS. 2005 Jul-Aug;113(7-8):550-4.

PMID:
16086826
[PubMed - indexed for MEDLINE]
17.

[Prognostic significance of micropapillary pattern in pulmonary adenocarcinoma].

Lin DM, Ma Y, Liu XY, Zheng S, Xue LY, Liu XY, Zou SM, Lü N, He ZG, Liu FS.

Zhonghua Bing Li Xue Za Zhi. 2006 Mar;35(3):151-4. Chinese.

PMID:
16630503
[PubMed - indexed for MEDLINE]
18.

Activation status of receptor tyrosine kinase downstream pathways in primary lung adenocarcinoma with reference of KRAS and EGFR mutations.

Hiramatsu M, Ninomiya H, Inamura K, Nomura K, Takeuchi K, Satoh Y, Okumura S, Nakagawa K, Yamori T, Matsuura M, Morikawa T, Ishikawa Y.

Lung Cancer. 2010 Oct;70(1):94-102. doi: 10.1016/j.lungcan.2010.01.001. Epub 2010 Feb 1.

PMID:
20117855
[PubMed - indexed for MEDLINE]
19.

Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).

Lim EH, Zhang SL, Li JL, Yap WS, Howe TC, Tan BP, Lee YS, Wong D, Khoo KL, Seto KY, Tan L, Agasthian T, Koong HN, Tam J, Tan C, Caleb M, Chang A, Ng A, Tan P.

J Thorac Oncol. 2009 Jan;4(1):12-21. doi: 10.1097/JTO.0b013e3181913e28.

PMID:
19096301
[PubMed - indexed for MEDLINE]
20.

Impact of GLUT1 and Ki-67 expression on early‑stage lung adenocarcinoma diagnosed according to a new international multidisciplinary classification.

Maki Y, Soh J, Ichimura K, Shien K, Furukawa M, Muraoka T, Tanaka N, Ueno T, Yamamoto H, Asano H, Tsukuda K, Toyooka S, Miyoshi S.

Oncol Rep. 2013 Jan;29(1):133-40. doi: 10.3892/or.2012.2087. Epub 2012 Oct 17.

PMID:
23076555
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk